# APBA1

## Overview
The APBA1 gene encodes the protein amyloid beta precursor protein binding family A member 1, also known as X11α or Mint1, which is a neuronal adaptor protein. This protein is characterized by its phosphotyrosine-binding (PTB) domain and two PSD-95/discs large/ZO-1 (PDZ) domains, which facilitate its interactions with various proteins, including the amyloid precursor protein (APP) and neurexins. X11α plays a crucial role in the processing of APP, influencing amyloid-beta production, which is significant in the context of Alzheimer's disease. Additionally, it is involved in synaptic vesicle trafficking and neurotransmitter release, highlighting its importance in neuronal communication and synaptic function. The protein also forms complexes with CASK and STXBP1, which are essential for insulin secretion, indicating its involvement in molecular transport processes related to exocytosis (Chai2012Genomic; Zhang2021CASK).

## Structure
The APBA1 protein, also known as X11α or Mint1, is a neuronal adaptor protein characterized by several distinct domains that facilitate its interactions with other proteins. It contains a phosphotyrosine-binding (PTB) domain, which interacts with the YENPTY motif of the amyloid precursor protein (APP), stabilizing APP and reducing amyloid-beta levels (Chai2012Genomic). Additionally, APBA1 has two PSD-95/discs large/ZO-1 (PDZ) domains involved in synaptic vesicle trafficking (Chai2012Genomic). The protein also includes a CASK-interacting domain (CI domain) that spans residues 331-432, which is crucial for its interaction with CASK and STXBP1 during insulin secretion (Zhang2021CASK).

APBA1 undergoes post-translational modifications such as phosphorylation, which can influence its interactions and functions. The protein is subject to transcriptional regulation, with Sp3 playing a significant role in its expression by binding to GC-rich regions in the promoter of the APBA1 gene (Chai2012Genomic). Multiple splice variants of APBA1 exist, contributing to its functional diversity, although specific details on these variants are not provided in the context. The protein's structure and interactions are essential for its roles in neurobiological functions and insulin secretion.

## Function
The human gene APBA1 encodes the protein X11α, also known as MINT1, which functions as an adaptor protein with a phosphotyrosine-binding domain. X11α is involved in the processing of the amyloid precursor protein (APP) by binding to its conserved YENPTY motif. This interaction is significant in the context of Alzheimer's disease, as it influences APP processing and amyloid β-protein (Aβ) production. Overexpression of X11α has been shown to reduce Aβ production by inhibiting γ-secretase cleavage of APP, suggesting a role in stabilizing APP and potentially reducing Aβ levels (Xie2005RNA).

In addition to its role in APP processing, APBA1 is involved in synaptic function. It forms a complex with proteins such as CASK and STXBP1, which is crucial for insulin secretion. This tripartite complex translocates from the cytoplasm to the plasma membrane during insulin secretion, indicating a role in molecular transport processes related to exocytosis (Zhang2021CASK). APBA1's interactions with other proteins, such as Munc18-1 and neurexins, suggest its involvement in synaptic vesicle exocytosis and neurotransmitter release, highlighting its importance in neuronal communication (Biederer2000Mints).

## Clinical Significance
Mutations and alterations in the expression of the APBA1 gene have been associated with various health conditions, particularly neurodegenerative diseases such as Alzheimer's disease. APBA1, also known as amyloid beta precursor protein binding family A member 1, plays a critical role in the processing of amyloid precursor protein (APP), which is central to the pathology of Alzheimer's disease. Studies have shown that alterations in APBA1 can influence the cleavage of APP, affecting the production of amyloid-beta (Aβ) peptides, which are implicated in the formation of amyloid plaques, a hallmark of Alzheimer's disease (Ho2008Deletion).

Research involving the deletion of Mint proteins, which include APBA1, in transgenic mouse models of Alzheimer's disease demonstrated a decrease in amyloid production and plaque formation. This effect is attributed to reduced extracellular cleavage of APP by β-secretase, while γ-secretase activity remains unaffected (Ho2008Deletion). These findings suggest that APBA1 may regulate APP processing through its role in protein trafficking, potentially affecting APP's secretory or endocytotic pathways (Ho2008Deletion). The study highlights the potential of targeting APBA1 interactions as a therapeutic strategy for reducing amyloid production in Alzheimer's disease (Ho2008Deletion).

## Interactions
The human gene APBA1 encodes the protein X11α, which is involved in several significant protein interactions. X11α interacts with the amyloid precursor protein (APP) through its phosphotyrosine binding (PTB) domain, specifically binding to the YENPTY motif in the cytoplasmic domain of APP. This interaction is crucial in the context of Alzheimer's disease, as it stabilizes APP and reduces amyloid-beta (Aβ) production, a key factor in the disease's pathogenesis (Chai2012Genomic; Xie2005RNA).

X11α also interacts with the transcription factor fibrinogen silencer binding protein to suppress the human glycogen synthase kinase 3b (GSK3b) promoter, which is involved in tau hyperphosphorylation, another pathological feature of Alzheimer's disease (Chai2012Genomic). Additionally, X11α forms complexes with CASK and STXBP1, which are involved in insulin secretion. CASK enhances the interaction between APBA1 and STXBP1, and this interaction is crucial for proper insulin secretion (Zhang2021CASK).

X11α also binds to neurexins through its PDZ domains, forming complexes with proteins like Munc18-1 and CASK, which are involved in synaptic vesicle exocytosis and neurotransmitter release (Biederer2000Mints).


## References


[1. (Chai2012Genomic) Ka-Ho Chai, Declan M. McLoughlin, Ting Fung Chan, Ho Yin Edwin Chan, and Kwok-Fai Lau. Genomic organization and promoter cloning of the human x11α geneapba1. DNA and Cell Biology, 31(5):651–659, May 2012. URL: http://dx.doi.org/10.1089/dna.2011.1447, doi:10.1089/dna.2011.1447. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.1089/dna.2011.1447)

[2. (Ho2008Deletion) Angela Ho, Xinran Liu, and Thomas C. Südhof. Deletion of mint proteins decreases amyloid production in transgenic mouse models of alzheimer’s disease. The Journal of Neuroscience, 28(53):14392–14400, December 2008. URL: http://dx.doi.org/10.1523/jneurosci.2481-08.2008, doi:10.1523/jneurosci.2481-08.2008. This article has 59 citations.](https://doi.org/10.1523/jneurosci.2481-08.2008)

[3. (Zhang2021CASK) Kai Zhang, Tianyuan Wang, Xingjing Liu, Qingzhao Yuan, Tin Xiao, Xiangjiang Yuan, Yijian Zhang, Li Yuan, and Yao Wang. Cask, apba1, and stxbp1 collaborate during insulin secretion. Molecular and Cellular Endocrinology, 520:111076, January 2021. URL: http://dx.doi.org/10.1016/j.mce.2020.111076, doi:10.1016/j.mce.2020.111076. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.mce.2020.111076)

[4. (Xie2005RNA) Zhongcong Xie, Donna M. Romano, and Rudolph E. Tanzi. Rna interference-mediated silencing of x11α and x11β attenuates amyloid β-protein levels via differential effects on β-amyloid precursor protein processing. Journal of Biological Chemistry, 280(15):15413–15421, April 2005. URL: http://dx.doi.org/10.1074/jbc.M414353200, doi:10.1074/jbc.m414353200. This article has 58 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M414353200)

[5. (Biederer2000Mints) Thomas Biederer and Thomas C. Südhof. Mints as adaptors. Journal of Biological Chemistry, 275(51):39803–39806, December 2000. URL: http://dx.doi.org/10.1074/jbc.c000656200, doi:10.1074/jbc.c000656200. This article has 196 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.c000656200)